1. Prognostic Role of the FGFR4-388Arg Variant in Lung Squamous-Cell Carcinoma Patients With Lymph Node Involvement
   Álvaro Quintanal-Villalonga et al, 2017, Clinical Lung Cancer CrossRef
2. The fibroblast growth factor 8 family in the female reproductive tract
   Anthony Estienne et al, 2018 CrossRef
3. The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction
   Álvaro Quintanal-Villalonga et al, 2018, Sci Rep CrossRef
4. Making way for suppressing the FGF19/FGFR4 axis in cancer
   Nestor Prieto-Dominguez et al, 2018, Future Medicinal Chemistry CrossRef
5. Fibroblast Growth Factor Receptor 4 Targeting in Cancer: New Insights into Mechanisms and Therapeutic Strategies
   Liwei Lang et al, 2019, Cells CrossRef
6. MicroRNA-520e restricts the proliferation and invasion of glioma cells through the downregulation of Wnt/β-catenin signaling by targeting fibroblast growth factor 19
   Liang Zhang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
7. Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives
   Emmanuel Somm et al, 2018 CrossRef
8. Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression
   Liwei Lang et al, 2018, CCDT CrossRef
9. Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer
   Sabine Heublein et al, 2019, J Cancer Res Clin Oncol CrossRef
10. Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer
    Shunta Hori et al, 2018, Oncotarget CrossRef
11. Current insights into the metastasis of epithelial ovarian cancer - hopes and hurdles
    Meysam Yousefi et al, 2020, Cell Oncol. CrossRef
12. Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate Cancer cell lines
    Shun Ying Quah et al, 2021, Toxicology and Applied Pharmacology CrossRef
13. The FGFR Family Inhibitor AZD4547 Exerts an Antitumor Effect in Ovarian Cancer Cells
    Yu Ran Na et al, 2021, IJMS CrossRef
14. FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer
    Wei Zhu et al, 2023 CrossRef
15. Ponatinib and gossypol act in synergy to suppress colorectal cancer cells by modulating apoptosis/autophagy crosstalk and inhibiting the FGF19/FGFR4 axis
    NaglaaM El-Lakkany et al, 2023, Asian Pac J Trop Biomed CrossRef
16. Fibroblast Growth Factor Receptors and Ligands in Context of Bevacizumab Response in Ovarian Carcinoma: An Exploratory Analysis of AGO-OVAR 11/ICON-7
    Sabine Heublein et al, 2023, Laboratory Investigation CrossRef
17. The anti-tumor effects of AZD4547 on ovarian cancer cells: differential responses based on c-Met and FGF19/FGFR4 expression
    Yoo-Young Lee et al, 2024, Cancer Cell Int CrossRef
18. Comprehensive in silico analysis of prognostic and immune infiltrates for FGFs in human ovarian cancer
    Yu Wang et al, 2024, J Ovarian Res CrossRef
19. Gossypol enhances ponatinib's cytotoxicity against human hepatocellular carcinoma cells by involving cell cycle arrest, p-AKT/LC3II/p62, and Bcl2/caspase-3 pathways
    Hadeel H. Elkattan et al, 2024, Toxicology Reports CrossRef